123 related articles for article (PubMed ID: 7870392)
1. Structural modifications of monoclonal antibodies following direct versus indirect labelling with 99Tcm: does fragmentation really occur?
Behr T; Becker W; Hannappel E; Wolf F
Nucl Med Commun; 1994 Nov; 15(11):865-70. PubMed ID: 7870392
[TBL] [Abstract][Full Text] [Related]
2. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
Behr T; Becker W; Hannappel E; Goldenberg DM; Wolf F
Cancer Res; 1995 Dec; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
[TBL] [Abstract][Full Text] [Related]
3. In vivo stability and metabolism of 99Tcm-labelled anti-CD4 monoclonal antibodies and Fab' fragments.
Kinne RW; Schemer K; Behr T; Sharkey RM; Palombokinne E; Emmrich F; Goldenberg DM; Wolf F; Becker W
Nucl Med Commun; 1999 Jan; 20(1):67-75. PubMed ID: 9949415
[TBL] [Abstract][Full Text] [Related]
4. Production and characterization of anti-human IgG F(ab')2 antibody fragment.
Valedkarimi Z; Nasiri H; Aghebati-Maleki L; Abdolalizadeh J; Esparvarinha M; Majidi J
Hum Antibodies; 2018; 26(4):171-176. PubMed ID: 29689714
[TBL] [Abstract][Full Text] [Related]
5. Radiochemical and radioimmunological data of 99Tcm-anti-CEA labelled by two diverse methods.
Varvarigou AD; Archimandritis SC; Sekeri-Pataryas K; Sourlingas TG; Sivolapenko G; Paschali E
Nucl Med Commun; 1996 Jan; 17(1):80-8. PubMed ID: 8692479
[TBL] [Abstract][Full Text] [Related]
6. Labelling small quantities of monoclonal antibodies and their F(ab')2 fragments with technetium-99m.
Tesic M; Sheldon KM; Ballinger JR; Boxen I
Nucl Med Biol; 1995 May; 22(4):451-7. PubMed ID: 7550021
[TBL] [Abstract][Full Text] [Related]
7. Structural perturbations of monoclonal antibodies following radiolabelling: in vitro evaluation of different techniques.
John E; Wilder S; Thakur ML
Nucl Med Commun; 1994 Jan; 15(1):24-8. PubMed ID: 8152689
[TBL] [Abstract][Full Text] [Related]
8. Optimal conditions for the preparation of Fab and F(ab')2 fragments from monoclonal IgG of different rat IgG subclasses.
Rousseaux J; Rousseaux-Prévost R; Bazin H
J Immunol Methods; 1983 Nov; 64(1-2):141-6. PubMed ID: 6644029
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the FO23C5 anti-CEA antibody fragment labelled with 99Tcm and 111In: a comparison in patients.
Hnatowich DJ; Mardirossian G; Rusckowski M; Roy S; Bushe H; Griffin TW; Brill AB
Nucl Med Commun; 1993 Jan; 14(1):52-63. PubMed ID: 8423936
[TBL] [Abstract][Full Text] [Related]
10. Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.
Glennie MJ; McBride HM; Worth AT; Stevenson GT
J Immunol; 1987 Oct; 139(7):2367-75. PubMed ID: 2958547
[TBL] [Abstract][Full Text] [Related]
11. Improved procedure for preparation of F(ab')2 fragments of mouse IgGs by papain digestion.
Boguslawski SJ; Ledden DJ; Fredrickson RA
J Immunol Methods; 1989 Jun; 120(1):51-6. PubMed ID: 2732475
[TBL] [Abstract][Full Text] [Related]
12. The binding parameters of radiolabelled monoclonal F (ab')2 and Fab' fragments relative to immunoglobulin G in reactions with surface-bound antigens.
Fjeld JG; Michaelsen TE; Nustad K
Eur J Nucl Med; 1992; 19(6):402-8. PubMed ID: 1618231
[TBL] [Abstract][Full Text] [Related]
13. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
14. Purification of antibody Fab and F(ab')2 fragments using Gradiflow technology.
Cheung GL; Thomas TM; Rylatt DB
Protein Expr Purif; 2003 Nov; 32(1):135-40. PubMed ID: 14680950
[TBL] [Abstract][Full Text] [Related]
15. The stability of 99Tcm directly labelled to an Fab' antibody via stannous ion and mercaptoethanol reduction.
Mardirossian G; Wu C; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 1992 Jul; 13(7):503-12. PubMed ID: 1495677
[TBL] [Abstract][Full Text] [Related]
16. Preparation of F(ab')2 fragments from monoclonal mouse IgG1 suitable for use in radioimaging.
Kurkela R; Vuolas L; Vihko P
J Immunol Methods; 1988 Jun; 110(2):229-36. PubMed ID: 3132507
[TBL] [Abstract][Full Text] [Related]
17. Anomalies in reduction-mediated technetium-99m labelling of monoclonal antibodies.
Pimm MV; Rajput RS; Frier M; Gribben SJ
Eur J Nucl Med; 1991; 18(12):973-6. PubMed ID: 1778209
[TBL] [Abstract][Full Text] [Related]
18. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
[TBL] [Abstract][Full Text] [Related]
20. Radiolabelling of monoclonal antibodies: optimization of conjugation of DTPA to F(ab')2-fragments and a novel measurement of the degree of conjugation using Eu(III)-labelling.
Hartikka M; Vihko P; Södervall M; Hakalahti L; Torniainen P; Vihko R
Eur J Nucl Med; 1989; 15(3):157-61. PubMed ID: 2469581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
